Before Zepbound, treatment options for OSA were ... alongside fatigue and injection site reactions. More serious risks like pancreatitis, kidney injury, and even thyroid tumors (observed in ...
Hosted on MSN1mon
FDA approves Zepbound: First prescription medication for obstructive sleep apnea in adultsZepbound can cause side effects such as nausea, diarrhoea, vomiting, constipation, abdominal (stomach) discomfort and pain, injection site reactions, fatigue, hypersensitivity (allergic ...
Joshua Cohen is a Boston-based writer who covers health policy. Patients on the weight-loss drug Zepbound regained weight almost one year after stopping treatment, according to a study published ...
A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less than what’s been seen with competitor Eli Lilly’s Zepbound.
Once again, the drugmaker reported sales of its blockbuster GLP-1 medicines Zepbound and Mounjaro that missed Wall Street estimates. It was the second consecutive miss for the two closely watched ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results